for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Avenue Therapeutics Reports Q4 Loss Per Share $0.63

March 1 (Reuters) - Avenue Therapeutics Inc:

* AVENUE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS

* Q4 LOSS PER SHARE $0.63 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up